secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2024-03-28T23:59:59+00:00
Accession:  0000950170-24-038153
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q4 revenues up 57% to $1.2M; full-year net loss narrows to $14.0M
-------------------------------------------------------------------------

- Q4 2023 product revenue $1.17M (+57% YoY); full-year revenue $5.33M (-28% from $7.42M due to prior-year grain sales and license revenue).
- Full-year net loss att. to common stockholders $13.98M ($11.30/share) vs $15.38M ($25.65/share) in 2022, improved by lower operating expenses.
- Cash, equivalents, and short-term investments totaled $11.6M at Dec. 31, 2023, down from $20.6M a year earlier; operating cash burn $15.3M.
- GoodWheat now in three categories (pasta, pancake/waffle mixes, mac & cheese) and >3,500 stores; Zola coconut water launched pineapple and lime flavors in Q1 2024.
- Company initiated strategic review in mid-2023 with Lake Street Capital Markets to explore M&A, sale, or other transactions to maximize GoodWheat value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024038153/0000950170-24-038153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017024038153/rkda-20240328.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-038153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer